ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in ADC Therapeutics SA as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 118
- +5 vs. Q4 2025
- Shares held
- 83.5M
- +2.46M (+3.0%) vs. Q4 2025
- Total value
- $312.9M
- +$26.5M (+9.2%) vs. Q4 2025
- New holders
- 19
- 53 more added
- Sold out
- 14
- 28 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $86.3M |
| Q1 2026 | 118 | $312.9M |
| Q4 2025 | 115 | $292.8M |
| Q3 2025 | 106 | $271.3M |
| Q2 2025 | 86 | $182.1M |
| Q1 2025 | 82 | $77.3M |
| Q4 2024 | 83 | $112.4M |
| Q3 2024 | 77 | $172.9M |
| Q2 2024 | 74 | $163.7M |
| Q1 2024 | 37 | $155.8M |
| Q4 2023 | 38 | $56.4M |
| Q3 2023 | 41 | $35.4M |
| Q2 2023 | 56 | $97.5M |
| Q1 2023 | 59 | $90.9M |
| Q4 2022 | 60 | $149.1M |
| Q3 2022 | 66 | $176.5M |
| Q2 2022 | 58 | $274.1M |
| Q1 2022 | 49 | $501.3M |
| Q4 2021 | 55 | $682.8M |
| Q3 2021 | 53 | $890.6M |
| Q2 2021 | 56 | $816.3M |
| Q1 2021 | 59 | $801.3M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding ADC Therapeutics SA; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Panagora Asset Management Inc | 691,275 | $2.59M | 0.01% | +97,019+16.3% | Added |
| BNP Paribas Arbitrage, SA | 860,491 | $3.23M | 0.00% | +29,588+3.6% | Added |
| Platinum Investment Management Ltd | 990,778 | $3.72M | 0.94% | 00.0% | Unchanged |
| Vanguard Portfolio Management LLC | 1,033,277 | $3.87M | 0.00% | +1,033,277 | New |
| Geode Capital Management, LLC | 1,203,756 | $4.51M | 0.00% | +207,233+20.8% | Added |
| OrbiMed Advisors LLC | 1,318,026 | $4.94M | 0.11% | −4,504,828−77.4% | Reduced |
| Bank of America Corp | 1,325,017 | $4.97M | 0.00% | +26,433+2.0% | Added |
| State Street Corp | 1,566,662 | $5.87M | 0.00% | +159,337+11.3% | Added |
| Goldman Sachs Group Inc | 1,653,026 | $6.20M | 0.00% | +12,154+0.7% | Added |
| Millennium Management LLC | 3,119,154 | $11.7M | 0.01% | +2,790,725+849.7% | Added |
| Point72 Asset Management, L.P. | 3,382,129 | $12.7M | 0.02% | −1,632,488−32.6% | Reduced |
| Morgan Stanley | 3,812,582 | $14.3M | 0.00% | +42,839+1.1% | Added |
| Nantahala Capital Management, LLC | 5,597,433 | $21.0M | 1.31% | +122,000+2.2% | Added |
| Eventide Asset Management, LLC | 5,701,655 | $21.4M | 0.35% | +2,337,588+69.5% | Added |
| BlackRock, Inc. | 6,250,747 | $23.4M | 0.00% | +823,438+15.2% | Added |
| Prosight Management, LP | 8,300,000 | $31.1M | 5.10% | −177,338−2.1% | Reduced |
| TCG Crossover Management, LLC | 11,390,175 | $42.7M | 1.22% | 00.0% | Unchanged |
| Redmile Group, LLC | 15,470,502 | $58.0M | 3.84% | −196,229−1.3% | Reduced |
| StemPoint Capital LP | 0 | $0 | 0.00% | −502,570−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −120,567−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −24,448−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −20,889−100.0% | Sold out |
| Henrickson Nauta Wealth Advisors, Inc. | 0 | $0 | 0.00% | −19,411−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −16,078−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −16,067−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,071−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,710−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,687−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −1,725−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −222−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Vantage Consulting Group Inc | – | – | – | – | Not filed |